Release Date: 30/01/17 18:20 Summary: Quarterly Activities Report and Quarterly Cashflow Report Price Sensitive: Yes Download Document 2.4MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%